Rate and severity of HIV-associated dementia (HAD): Correlations with Gp41 and iNOS

Molecular Medicine

Volumn 5, Issue 2, 1999, Pages 98-109

  Adamson, D Cory ^a   McArthur, Justin C ^a,b   Dawson, Ted M ^a   Dawson, Valina L ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; BETA TUBULIN; COAT PROTEIN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; NITRIC OXIDE SYNTHASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; AUTOPSY; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOBLOTTING; LYMPHOCYTE COUNT; MACROPHAGE; MICROGLIA; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 0032930126     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402144     Document Type: Article

References (57)

1. McArthur JC. (1997) NeuroAIDS: diagnosis and management. Hosp. Prac. Aug: 73-97.
2. Navia BA, Jordan BD, Price RW. (1986) The AIDS dementia complex; I. Clinical features, Ann. Neurol. 19: 517-524.
3. Price RW, Brew B, Sidtis J, Rosenblum M, Scheck AC, Cleary P. (1988) The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239: 586-592.
4. Zheng J, Gendelman HE. (1997) The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. Curr. Opin. Neurol. 10: 319-325.
5. Glass JD, Fedor H, Wesselingh SL, McArthur JC. (1995) Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann. Neurol. 38: 755-762.
6. Takahashi K, Wesselingh SL, Griffin DE, McArthur JC, Johnson RT, Glass JD. (1996) Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann. Neurol. 39: 705-711.
7. Koenig S, Gendelman HE, Orenstein JM, et al. (1986) Detection of AIDS vims in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233: 1089-1093.
8. Dickson DW, Lee SC, Liu W, Brosnan CF. (1994) Microglial involvement in the acquired immunodeficiency syndrome (AIDS). Neuropathol. Appl. Neurobiol. 20: 211-213.
9. Tornatore C, Chandra R, Berger JR, Major EO. (1994) HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44: 481-487.
10. Tornatore C, Meyers K, Atwood W, Conant K, Major E. (1994) Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes. J. Virol. 68: 93-102.
11. Everall IP, Glass JD, McArthur J, Spargo E, Lantos P. (1994) Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementia. Acta Neuropathol. 88: 538-544.
12. Wiley CA, Masliah E, Morey M, et al. (1991) Neocortical damage during HIV infection. Ann. Neurol. 29: 651-657.
13. Masliah E, Ge N, Morey M, DeTeresa R, Terry RD, Wiley CA. (1992) Conical dendritic pathology in human immunodeficiency virus encephalitis, Lab. Invest. 66: 285-291.
14. Epstein LG, Gendelman HE. (1993) Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann. Neurol. 33: 429-436.
15. Lipton SA, Gendelman HE. (1995) Dementia associated with the acquired immunodeficiency syndrome. Seminars in medicine of the Beth Israel Hospital, Boston. N. Engl. J. Med. 332: 934-940.
16. Teo I, Veryard C, Barries H, et al. (1997) Circular forms of unintegrated human immunodeficiency virus type I DNA and high levels of viral protein expression: association with dementia and multinucleated giant cells in the brains of patients with AIDS. J. Virol 71: 2928-2933.
17. Pulliam L, Gascon R, Stubblebine M, McGuire D, McGrath MS. (1997) Unique monocyte subset in patients with AIDS dementia. Lancet 349: 692-695.
18. Brew BJ, Dunbar N, Penberton, Kaldor J. (1996) Predictive markers of AIDS dementia complex: CD4 count and cerebrospinal fluid concentrations of beta 2-microglobutin and neopterin. J. Infect. Dis. 174: 294-298.
19. Sacktor NC, Bacellar H, Hoover DR, et al. (1996) Psychomotor stowing in HIV infection: predictor of dementia, AIDS and death. J. Neurovirol. 2: 404-410.
20. Wiley CA, Achim CL. (1994) Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann. Neurol. 36: 673-676.
21. Brew BJ. (1996) Human immunodeficiency virus in brain and correlation with dementia. Ann. Neurol. 39: 828-829.
22. Pang S, Koyanagi Y, Miles S, Wiley C, Vinters HV, Chen IS. (1990) High levels of unintegrated HIV-1 DNA in brain tissue of AIDSdementia patients. Nature 343: 85-89.
23. Brew BJ, Pemberton L, Cunningham P, Law MG. (1997) Levels of human immunodeficiency virus type 1 RNA in ccrcbrospinal fluid correlate with AIDS dementia stage. J. Infect. Dis. 175: 963-966.
24. Adamson DC, Wildermann B, Sasaki M, et al. (1996) Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41 Science 274: 1917-1921.
25. Wiley CA, Nelson JA. (1990) Human immunodeficiency virus: infection of the nervous system. Curr. Top. Microbiol. Immunol. 160: 157-172.
26. Nuovo GJ, Alfieri ML. (1996) AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines. Mol. Med. 2: 358-366.
27. Chaisson RE, Keruly JC, Moore RD. (1995) Race, sex, drug use, and progression of human immunodeficiency virus disease. N. Engl. J. Med. 333: 751-756.
28. Operskalski EA, Stram DO, Lee H, et al. (1995) Human immunodeficiency virus type 1 infection: relationship of risk group and age to rate of progression to AIDS. J. Infect. Dis. 172: 648-655.
29. Saah AJ, Munoz A, Kuo V, et al. (1992) Predictors of risk of development of acquired immunodeficiency syndrome within 24 months among gay men seropositive for human immunodeficiency vims type I: a report from the Multicenter Center AIDS Cohort Study. Am. J. Epidemiol. 135: 1147-1155.
30. Von Overbeck J, Egger M, Smith GD, et al. (1994) Survival in HIV infection: do sex and category of transmission matter? Swiss HIV Cohort Study. AIDS 8: 1307-1313.
31. Cunningham AL, Naif H, Saksena N, et al. (1997) HIV infection of macrophages and pathogcncsis of AIDS dementia complex: interaction of the host cell and viral genotype. J. Leukoc. Biol. 62: 117-125.
32. Navia BA, Jordon BD, Price RW. (1986) The AIDS dementia complex: I. Clinical features. Ann. Neurol. 19: 517-524.
33. McArthur JC. (1987) Neurologic manifestations of AIDS. Medicine 66: 407-437.
34. Portegies P, Enting RH, de Gans J, et al. (1993) Presentation and course of AIDS dementia complex: ten years of follow-up in Amsterdam, The Netherlands. AIDS 7: 669-675.
35. Tozzi V, Narciso P, Galgani S, et al. (1993) Effects of zidovudine in 30 patients with mild to endstage AIDS dementia complex. AIDS 7: 683-692.
36. Bouwman FH, Skolasky R, Hes D, et al. (1998) Variable progression of HIV-associated dementia. Neurology 50: 1814-1820.
37. Janssen RS, Cornblath DR, Epstein LG, McArthur J, Price RW. (1991) Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 41: 778-785.
38. Price RW, Brew BJ. (1988) The AIDS dementia complex. J. Infect, Dis. 158: 1079-1083.
39. Folstein MF, Holstein SE, McHugh PR. (1975) Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12: 189-198.
40. Power C, McArthur JC, Johnson RT, et al. (1994) Demented and non-demented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J. Virol. 68: 4643-4649.
41. Toggas SM, Mastiah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L. (1994) Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367: 188-193.
42. Hill JM, Mervis RF, Avidor R, Moody TW, Brenneman DE. (1993) HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates. Brain Res. 603: 222-233.
43. Bukrinsky MI, Nottet HS, Schmidtmayerova H, et al. (1995) Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J. Exp. Med. 181: 735-745.
44. Bagasra O, Bobroski L, Sarkcr A, Bagasra A, Saikumari P, Pomerantz RJ. (1997) Absence of the inducible from of nitric oxide synthase in the brains of patients with the acquired immunodeficiency syndrome. J. Neurovirol. 3: 153-167.
45. Portegies P. (1995) The Neurology of HIV-1 Infection. MediTech Media, London.
46. Levy JA. (1993) The transmission of HIV and factors influencing progression to AIDS. Am. J. Med. 95: 86-100.
47. Galli RA, Castriciano S, Fearon M, Major C, Choi KW, Mahony J, Chernesky M. (1996) Performance characteristics of recombinant enzyme immunoassay to detect antibodies to human immunodeficiency virus type 1 (HIV-1) and HIV-2 and to measure early antibody responses in scroconverting patients. J. Clin. Microbiol. 34: 999-1002.
48. Pudney J, Anderson D. (1995) Effects of fixation and paraffin embedding on the immunohistological detection of cell-associated H1V-1 by different monoclonal antibodies. J. Histochem. Cytochem. 43: 857-862.
49. Portincasa P, Conti G, Zannino T, Visalli S, Chezzi C. (1994) Radioimmune western blotting in comparison with conventionalwestern blotting, second and third generation ELISA assays for the serodiagnosis of HIV-1 infection. New Microbiol. 17: 169-176.
50. Flaherty MT, Hauer DA, Mankowski JL, Zink MC, Clements JE. (1997) Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus. J. Virol. 71: 5790-5798.
51. Bird C, Burke J, Gleeson PA, McCluskey J. (1990) Expression of human immunodeficiency virus 1 (HIV-1 ) envelope gene products transcribed from a heterologous promoter. Kinetics of HIV-1 envelope processing in transfected cells. J. Biol. Chem. 265: 19151-19157.
52. Egan MA, Carruth LM, Rowell JF, Yu X, Siliciano RF. (1996) Human immunodeficiency vims type 1 envelope protein endocytosis mediated by a highly conserved intrinsic internalization signal in the cytoplasmic domain of gp41 is suppressed in the presence of the Pr55gag precursor protein. J. Virol. 70: 6547-6556.
53. Koka P, He K, Camerini D, Tran T, Yashar SS, Merrill JE. (1995) The mapping of HIV-1 gp160 epitopes required for interleukin-1 and tumor necrosis factor alpha production in gliat cells. J. Neuroimmunol 57: 179-191.
54. Koka P, He K, Zack JA, et al. (1995) Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in gliat cultures derived from fetal, neonatal, and adult human brain. J. Exp. Med. 182: 941-951.
55. Rabenstein MD, Shin YK. (1995) HIV-1 gp41 tertiary structure studied by EPR spectroscopy. Biochemistry 35: 13922-13928.
56. Wingfield PT, Stahl SJ, Kaufman J, et al. (1997) The extracellular domain of immunodeficiency virus gp41 protein: expression in Escherichia coli, purification, and crystallization. Protein Sci. 6: 1653-1660.
57. Adamson, DC, Kopnisky KL, Dawson TM, Dawson VL. (1999) Mechanisms and structural determinants of HIV-1 coat protein, gp41-induced neurotoxicity. J. Neurosci. 19: 64-71.